Structure and Mechanism of Copper- and Nickel-Substituted Analogues of Metallo-β-lactamase L1 by Hu, Zhenxin et al.
Marquette University 
e-Publications@Marquette 
Physics Faculty Research and Publications Physics, Department of 
4-2009 
Structure and Mechanism of Copper- and Nickel-Substituted 
Analogues of Metallo-β-lactamase L1 
Zhenxin Hu 
Miami University - Oxford 
Lauren J. Spadafora 
Miami University - Oxford 
Christine E. Hajdin 
Miami University - Oxford 
Brian Bennett 
Marquette University, brian.bennett@marquette.edu 
Michael W. Crowder 
Miami University - Oxford 
Follow this and additional works at: https://epublications.marquette.edu/physics_fac 
 Part of the Physics Commons 
Recommended Citation 
Hu, Zhenxin; Spadafora, Lauren J.; Hajdin, Christine E.; Bennett, Brian; and Crowder, Michael W., "Structure 
and Mechanism of Copper- and Nickel-Substituted Analogues of Metallo-β-lactamase L1" (2009). Physics 






Physics Faculty Research and Publications/College of Arts and Sciences 
 
This paper is NOT THE PUBLISHED VERSION; but the author’s final, peer-reviewed manuscript. The 
published version may be accessed by following the link in the citation below. 
 
Biochemistry, Vol. 48, No. 13 (7 April 2009): 2981–2989. DOI. This article is © American Chemical 
Society Publications and permission has been granted for this version to appear in e-
Publications@Marquette. American Chemical Society Publications does not grant permission for this 
article to be further copied/distributed or hosted elsewhere without the express permission from 
American Chemical Society Publications.  
 
Structure and Mechanism of Copper- and 




Department of Chemistry and Biochemistry, Miami University, Oxford, Ohio 
Lauren J. Spadafora 
Department of Chemistry and Biochemistry, Miami University, Oxford, Ohio 
Christine E. Hajdin 
Department of Chemistry and Biochemistry, Miami University, Oxford, Ohio 
Brian Bennett 
National Biomedical EPR Center, Department of Biophysics, Medical College of Wisconsin, Milwaukee, 
Wisconsin 
Michael W. Crowder 
Department of Chemistry and Biochemistry, Miami University, Oxford, Ohio 
†This work was supported by the National Institutes of Health (AI056231 to B.B. and EB001980 to the Medical 
College of Wisconsin) and Miami University/Volwiler Professorship (to M.W.C.). 
SUBJECTS: 




In an effort to further probe metal binding to metallo-β-lactamase L1 (mβl L1), Cu- (Cu-L1) and Ni-substituted 
(Ni-L1) L1 were prepared and characterized by kinetic and spectroscopic studies. Cu-L1 bound 1.7 equiv of Cu 
and small amounts of Zn(II) and Fe. The EPR spectrum of Cu-L1 exhibited two overlapping, axial signals, 
indicative of type 2 sites with distinct affinities for Cu(II). Both signals indicated multiple nitrogen ligands. 
Despite the expected proximity of the Cu(II) ions, however, only indirect evidence was found for spin−spin 
coupling. Cu-L1 exhibited higher kcat (96 s−1) and Km (224 μM) values, as compared to the values of dinuclear 
Zn(II)-containing L1, when nitrocefin was used as substrate. The Ni-L1 bound 1 equiv of Ni and 0.3 equiv of Zn(II). 
Ni-L1 was EPR-silent, suggesting that the oxidation state of nickel was +2; this suggestion was confirmed by 1H 
NMR spectra, which showed relatively sharp proton resonances. Stopped-flow kinetic studies showed that ZnNi-
L1 stabilized significant amounts of the nitrocefin-derived intermediate and that the decay of intermediate is 
rate-limiting. 1H NMR spectra demonstrate that Ni(II) binds in the Zn2 site and that the ring-opened product 
coordinates Ni(II). Both Cu-L1 and ZnNi-L1 hydrolyze cephalosporins and carbapenems, but not penicillins, 
suggesting that the Zn2 site modulates substrate preference in mβl L1. These studies demonstrate that the 
Zn2 site in L1 is very flexible and can accommodate a number of different transition metal ions; this flexibility 
could possibly offer an organism that produces L1 an evolutionary advantage when challenged with β-lactam-
containing antibiotics. 
β-Lactams are inexpensive and widely used antibiotics against microbes since the 1940s (1). There are three 
different major classes of β-lactams, penicillins, cephalosporins, and carbapenems, that have been used 
clinically. However, most microorganisms have obtained the ability to either pump the β-lactams out of the cell 
via transporter proteins (2) or to hydrolyze these compounds by secreting β-lactamases into the periplasm or 
milieu (3). Four distinct classes of β-lactamases have been identified (4). Unlike class A, C, and D β-lactamases, 
which utilize an active site serine as a nucleophile, class B β-lactamases, metallo-β-lactamases or Μβl’s, are a 
group of enzymes that require Zn(II) to hydrolyze β-lactams (5). There have been >50 Mβl’s identified and 
categorized into three subgroups, according to amino acid sequence homology, the requirement of Zn(II) (1 or 2) 
for maximal activity, the identity of the metal binding ligands, and substrate preference. Although the amino 
acid sequence homology is less than 30% between the different subgroups of Mβl’s, the Zn(II) binding motif, 
HXHXD, is highly conserved (5). Most Mβl’s have a Zn1 site, consisting of three histidines and one bridging 
hydroxide, and a relatively more variable Zn2 site, consisting of two histidines (or one histidine and one cysteine 
in B1 and B2 Mβl’s), one aspartate, one terminally bound water, and the bridging hydroxide (Figure 1). 
 
Figure 1. Active site of Mβl L1. The metal ion in the Zn1 site is coordinated by three histidines (His116, His118, 
and His196) and one bridging hydroxide (sphere in between two metal ions). The metal ion in the Zn2 site is 
coordinated by two histidines (His121 and His263), one aspartate (Asp120), one bridging hydroxide, and one 
terminally bound H2O (not shown). 
 
Since the electronic configuration of Zn(II) is Ar[d10], which makes the metal center in Mβl’s spectroscopically 
silent with the most common techniques (6), Zn(II) has often been replaced by Co(II), resulting in catalytically 
active analogues that can be characterized by a number of common spectroscopic techniques (7-10). The Zn(II) 
ions have also been substituted with Cd(II) in Mβl CcrA1(11), and this analogue was catalytically active and was 
characterized with 119Cd NMR spectroscopy (12). While the Mβl’s demonstrate a preference for Zn(II) binding, 
Crowder and co-workers have recently reported that the metalation of Mβl L1 depends on the bioavailability of 
metal ions (13). In these studies, L1 was shown to bind Fe, Zn(II), and Mn. This result suggests that L1 contains a 
highly flexible metal binding site like that previously reported for plant glyoxalase 2’s (14, 15), raising the 
question of whether other first row transition metal ions could bind to L1. In this work, we explored whether Ni- 
and Cu-containing analogues of L1 could be prepared, and we characterized the resulting analogues using 
spectroscopic and kinetic studies. These studies demonstrate that Cu- and Ni-containing analogues of L1 are 
active and suggest that the flexible metal binding site in L1 offers organisms an evolutionary advantage by being 
able to produce an enzyme that confers antibiotic resistance in environments containing transition metal ions 
other than Zn(II). 
Abbreviations: AAP, aminopeptidase from Aeromonas proteolytica; CcrA, metallo-β-lactamase from Bacteroides 
fragilis; EPR, electron paramagnetic resonance; EXAFS, extended X-ray absorption fine structure; Hepes, 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid; ICP-AES, inductively coupled plasma−atomic emission 
spectroscopy; L1, metallo-β-lactamase from Stenotrophomonas maltophilia; mT, millitesla. 
Experimental Procedures 
Preparation of Ni- and Cu-Containing Analogues of L1 
Mature L1 (M-L1) was overexpressed as previously described, and 100 μM NiSO4 or CuSO4 was added to the 
minimal medium during cell growth and protein production (16, 17). After protein overexpression 
the Escherichia coli cells were centrifuged for 15 min (8200g), and the cell pellet was resuspended in 300 mL of 
50 mM Hepes (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), pH 6.0. The suspension was centrifuged for 
15 min (8200g), and the resulting pellet was resuspended in 50 mM Hepes, pH 6.0. The cells were lysed by using 
a French press as previously described (18), and the mixture was centrifuged for 25 min (23400g). The cleared, 
crude protein solution was loaded onto a 25 mL SP-Sepharose column that was equilibrated with 50 mM Hepes, 
pH 6.0, and bound proteins were eluted from the column using a linear 0−500 mM NaCl gradient in the same 
buffer. L1 typically eluted at 80−120 mM NaCl, and the fractions were analyzed for the presence of L1 by using 
SDS−PAGE, as previously described (18). 
Metal Analyses 
The metal content of the protein samples was determined by using a Varian Liberty 150 inductively coupled 
plasma spectrometer with atomic emission spectroscopy detection (ICP-AES). All of the proteins were diluted to 
10 μM with 50 mM Hepes, pH 7.0. A calibration curve with four standards and a correlation coefficient of 
greater than 0.999 was generated using Zn(II), Cu, and Ni reference solutions from Fisher Scientific. The 
following emission wavelengths were chosen to ensure the lowest detection limits possible: Zn(II), 213.856 nm; 
Cu, 324.754 nm; and Ni, 221.647 nm. 
1H NMR Spectroscopy 
1H NMR spectra were collected on a Bruker Avance 500 spectrometer operating at 500.13 MHz, 298 K, magnetic 
field of 11.7 T, recycle delay (AQ) of 41 ms, and sweep width of 400 ppm. Proton chemical shifts were calibrated 
by assigning the H2O signal the value of 4.7 ppm. A modified presaturation pulse sequence (zgpr) was used to 
suppress the proton signals originating from solvent. The presaturation pulse was as short as possible (500 ms) 
to avoid saturation of paramagnetically shifted proton signals. The concentration of NMR samples was generally 
in the range of 1.0−1.2 mM. Samples in D2O were prepared by performing three or more dilution/concentration 
cycles in a Centricon-10. 
EPR Spectroscopy 
Low-temperature EPR spectroscopy was carried out using a Bruker EleXsys E600 spectrometer equipped with an 
Oxford Instruments ITC503 liquid helium flow system. EPR spectra were recorded at 9.63 GHz using an 
ER4116DM cavity, with 0.4 mT (4 G) magnetic field modulation at 100 kHz. Other EPR recording parameters are 
given in the legends to figures. Computer simulations were carried out using XSophe v.1.1.4 (Bruker Biospin). 
Steady-State Kinetics 
All kinetic studies were conducted on an Agilent 8453 UV−vis diode array spectrophotometer at 25 °C. Steady-
state kinetic parameters, the Michaelis constant Km and the turnover number kcat, were determined by 
monitoring product formation at 485 nm using nitrocefin or substrate decay at 235 nm for pencillin G, 280 nm 
for cefaclor, or 295 nm for imipenem in 50 mM Chelex-treated cacodylate, pH 7.0. Absorbance changes were 
converted to concentration changes using Beer’s law and the extinction coefficients (in M−1 cm−1) of nitrocefin 
product (17420), penicillin G (−926), cefaclor (−6410), or imipenem (−9000), respectively. 
Stopped-Flow Kinetic Studies 
Stopped-flow kinetic experiments were performed on an Applied Photophysics SX18MV spectrophotometer 
equipped with a constant temperature circulating water bath as previously described (19). All experiments were 
performed in 50 mM Chelex-treated cacodylate buffer, pH 7.0, at 10 °C. All of the proteins were diluted with 50 
mM Chelex-treated cacodylate buffer to 100 μM, and nitrocefin was prepared and diluted to 100 μM in the 
same buffer. The progress UV−vis and fluorescence curves were fitted with the single or double exponential 
equation. 
Results 
Preparation and Characterization of Ni(II)- and Cu(II)-Containing Analogues of L1 
L1 was overexpressed using an overexpression plasmid that contains the gene for mature L1 (M-L1), which lacks 
the N-terminal targeting sequence (20). This overexpression plasmid has been previously used to prepare Fe-
containing analogues of L1 that are folded in the cytoplasm of E. coli. When M-L1 was overexpressed in minimal 
medium containing 100 μM Cu(II), 5 mg of purified protein could be obtained per liter of growth medium. The 
resulting protein was shown to bind 1.7 ± 0.1 (Table 1) equiv of Cu, 0.10 ± 0.05 equiv of Zn(II), and 0.20 ± 0.05 
equiv of Fe. When M-L1 was overexpressed in minimal medium containing 100 μM Ni(II), 4 mg of purified 
protein could be obtained per liter of growth medium. The resulting protein was shown to bind 1.0 ± 0.1 equiv 
of Ni, 0.30 ± 0.05 equiv of Zn(II), and no other metal ions at greater than 0.03 equiv. 
Table 1. Steady-State Kinetic Studiesa and Metal Analyses on Cu- and Ni-Containing Analogues of L1 
analogue kcat (s−1) Km (μM) metal content (equiv) 
ZnZn-L1b 26 ± 1 4 ± 1 1.9 ± 0.1 Zn(II) 
Cu-L1 96 ± 8 224 ± 20 1.7 ± 0.1 Cu 
      0.10 ± 0.05 Zn(II) 
      0.20 ± 0.05 Fe 
Ni-L1c 24 ± 2 18 ± 2 0.30 ± 0.05 Zn(II) 
      1.0 ± 0.1 Ni 
NiZn-L1d 36 ± 1 16 ± 1 1.0 Zn(II), 1.0 Ni(II) 
aSteady-state kinetic studies were conducted at 25 °C in 50 mM Chelex-treated cacodylate, pH 7.0, using 
nitrocefin as the substrate. 
bData from ref 21. 
cAs-isolated Ni-L1. 
dSample prepared by direct addition of Zn(II) to as-isolated Ni-L1. 
 
The Cu- and Ni-containing analogues of L1 were characterized using steady-state kinetic studies. As-isolated Cu-
containing L1 (called Cu-L1), which contained 1.7 equiv of Cu (Table 1), exhibited a kcat of 96 ± 8 s−1 and a Km of 
224 ± 20 μM, when using nitrocefin as substrate. While exhibiting a larger kcat than wild-type L1, which binds 1.9 
equiv of Zn(II), Cu-L1 exhibits a Km that is 56 times larger than that of ZnZn-L1, resulting in a kcat/Km value that is 
>10-fold lower than that of ZnZn-L1. The as-isolated Ni-containing analogue of L1 (called Ni-L1) exhibited a kcat of 
24 ± 2 s−1 and a Km of 18 ± 2 μM, when using nitrocefin as substrate. Zn(II) (0.7 equiv) was added to as-isolated 
Ni-containing L1 to generate ZnNi-L1, and this analogue exhibited a kcat of 36 ± 1 s−1 and a Km of 18 ± 1 μM. 
In order to test the substrate specificity of the Cu- and Ni-containing analogues of L1, three different substrates, 
penicillin G, cefaclor, and imipenem, were used in steady-state kinetic studies with the metal-substituted forms 
of L1, and the results from these studies were compared to results with ZnZn-L1 (Table 2). When cefaclor, a 
cephalosporin like nitrocefin, was used as substrate, Cu- and Ni-containing L1 exhibited kcat values similar to 
those exhibited by ZnZn-L1; however, the Km values exhibited by both metal-substituted analogues were 
significantly higher. With the carbapenem imipenem as substrate, Cu- and ZnNi-L1 exhibited much 
higher kcat and Km values than ZnZn-L1. The largest difference in kinetic behavior, however, was observed when 
penicillins were used as substrates. Neither Cu- nor ZnNi-L1 hydrolyzed penicillin G (Table 2) or ampicillin, while 
the ZnZn analogue hydrolyzed penicillin G with a high kcat value. 
Table 2. Steady-State Kineticsa of Different L1 Analogues with Different Substrates 
    penicillin G cefaclor imipenem 
ZnZn-L1 kcat (s−1) 761 38 13 
  Km (μM) 278 8 2 
  kcat/Km (μM−1 s−1) 2.7 4.8 6.5 
ZnCo-L1 kcat (s−1) 692 26 12 
  Km (μM) 218 40 23 
  kcat/Km (μM−1 s−1) 3.2 0.65 0.52 
CoCo-L1 kcat (s−1) 118 14 43 
  Km (μM) 36 43 13 
  kcat/Km (μM−1 s−1) 3.3 0.33 3.3 
ZnFe-L1 kcat (s−1) <1 16 59 
  Km (μM) ND 35 27 
  kcat/Km (μM−1 s−1) ND 0.46 2.2 
Cu-L1 kcat (s−1) <1 29 205 
  Km (μM) ND 58 42 
  kcat/Km (μM−1 s−1) ND 0.50 4.9 
ZnNi-L1 kcat (s−1) <1 27 166 
  Km (μM) ND 91 61 
  kcat/Km (μM−1 s−1) ND 0.30 2.7 
aSteady-state kinetic studies were conducted at 25 °C in 50 mM Chelex-treated cacodylate, pH 7.0. Standard 
deviation < 10%. ND = not determined. 
 
To test whether other metal-substituted analogues of L1 exhibited similar substrate specificity profiles, the 
ZnCo-, CoCo-, and ZnFe analogues were prepared as previously reported (13, 20, 21) and used in steady-state 
kinetic studies with the same substrates (Table 2). The ZnCo analogue exhibited steady-state kinetic constants 
most similar to those of ZnZn-L1; however, the ZnCo analogue did exhibit Km values for cephalosporins and 
carbapenems much higher than those of ZnZn-L1. The CoCo analogue of L1 exhibited activity with all substrates 
tested; however, this analogue exhibited a much lower Km value for penicillins and higher Km values for 
cephalosporins and penicillins as compared to those of ZnZn-L1. The ZnFe analogue of L1 behaved similarly as 
Cu-L1 and ZnNi-L1 with respect to the values of Km; however, this analogue did not exhibit the higher kcat values 
that were exhibited by Cu- and ZnNi-L1. Like Cu- and ZnNi-L1, the ZnFe analogue of L1 exhibited no hydrolysis 
activity toward pencillin G. 
Spectroscopic Studies on Cu- and Ni-Containing Analogues of L1 
As-isolated Cu-L1 was pale blue, and the UV−vis spectrum of the enzyme revealed a broad peak between 500 
and 950 nm (molar absorptivity at 780 nm of 120 M−1 cm−1) (data not shown). In contrast, the as-isolated Ni-
containing analogue of L1 was pale green; however, there were no resolved UV−vis peaks between 330 and 
1000 nm, although there was a broad, low-intensity absorbance starting at 500 nm and extending to almost 
1000 nm. The EPR spectrum of L1 (Figure 2) was complex, but some information was available from computer 
simulations. Comparison of the spectra recorded at 0.1 mW and at 2 mW indicated that the spectrum was 
comprised of a component that exhibited a resolved 63/65Cu hyperfine pattern in the g∥ region and an additional 
component that was most evident as an broad feature at 2900−3250 G (290−325 mT) and that exhibited no 
resolved hyperfine lines. The component with resolved Cu hyperfine appeared to account for an estimated 65% 
of the total Cu(II) and was itself a mixture of two species, as is evident from the number and intensity of 
hyperfine lines (Figure 2B). A very good simulation of the resolved features in the 63/65Cu hyperfine region of the 
spectrum was obtained assuming two species, both indicative of type 2 Cu(II) with nitrogen ligation. The major 
component accounted for 70% of the resolved signal (45% of Cu(II)) and exhibited g∥ = 2.284 and A∥(Cu) = 15.5 × 
103 cm−1 (full and detailed parameters for the simulations are given in the caption to Figure 2). 
Peisach−Blumberg analysis (Figure 3A) (22) suggests three nitrogen ligands and one oxygen ligand in the 
equatorial coordination plane for this copper ion. The minor component accounted for 30% of the resolved 
signal (20% of Cu(II)) and exhibited g∥ = 2.222 and A∥(Cu) = 16.0 × 10−3 cm−1. These values do not lie in a well-
defined region of the Peisach−Blumberg diagram (Figure 3B) but are consistent with nitrogen ligands in the 
equatorial plane and additional ligation by some moiety with electron-withdrawing character, though perhaps 
not so much as a thiolate ligand. 
 
Figure 2. EPR spectrum from Cu(II)-containing L1. (A) Experimental ∂χ′′/∂B EPR spectrum recorded at 10 K, 0.1 
mW microwave power (thick line) and 10 K, 2 mW power (thin line). (B) Derivative (∂2χ′′/∂B2) of the 63/65Cu 
hyperfine region of the spectrum. (C) Simulation of (B) assuming two species; the spin Hamiltonian parameters 
for the major species (accounting for 70% of the spins) were g∥ = 2.284, A∥(Cu) = 15.5 × 10−3 cm−1, g⊥ = 
2.055, A⊥(Cu) = 1.10 × 10−3 cm−1, A⊥(3 × 14N) = 1.35 × 10−3 cm−1; the parameters for the minor species (30%) 
were g∥ = 2.222, A∥(Cu) = 16.0 × 10−3 cm−1, g⊥ = 2.032. (D) Derivative (∂2χ′′/∂B2) of the g⊥ region of the spectrum. 
(E−G) Calculated ∂2χ′′/∂B2 spectra, assuming g∥ = 2.284, A∥(Cu) = 15.5 × 10−3 cm−1, g⊥ = 2.055 ± 0.005, and 
(E) A⊥(Cu) = 1.10 × 10−3 cm−1, A⊥(3 × 14N) = 1.35 × 10−3 cm−1; (F) A⊥(3 × 14N) = 1.35 × 10−3 cm−1; (G) A⊥(Cu) = 1.10 × 
10−3 cm−1, A⊥(2 × 14N) = 1.35 × 10−3 cm−1; (H) A⊥(Cu) = 1.60 × 10−3 cm−1, A⊥(2 × 14N) = 1.35 × 10−3 cm−1. 
 
 
Figure 3. Peisach−Blumberg plot showing the suggested coordination for the major (A) and minor (B) species of 
Cu(II) in L1. 
 
Further information from the spectra was obtained from an analysis of the g⊥ region of the spectrum 
(Figure 2D). A well-resolved superhyperfine pattern was exhibited in this region, and simulations indicated that 
this pattern was associated with the major component of the spectrum. The g⊥ region of Cu(II) spectra, 
particularly at X-band, is difficult to interpret due to contributions from 63/65Cu, 14N, and the angular anomaly, or 
“overshoot” line. However, comparison of matrix diagonalization simulations was instructive. A simulation 
(Figure 2E) assuming a single, relatively small A⊥ due to copper, and a splitting due to three nitrogen ligands with 
typical superhyperfine coupling constants, reproduced all of the features in the experimental spectrum with 
faithful reproduction of their intensities. Other models with only three nitrogens and no copper (Figure 2F), or 
with two nitrogens and a range of copper coupling constants (e.g., Figure 2G,H), either did not return the correct 
relative intensities or did not reproduce all of the features in the experimental spectrum. Thus, the higher 
affinity Cu(II) species in L1 is characterized by at least three equatorial nitrogen ligands. 
In addition to the spectral features that were characterized by simulation, some broad absorption between 290 
and 320 mT (2900−3200 G) was observed that resisted saturation more than the type 2 signals (Figure 2A). Slight 
changes to the shape of the high-field side of the g⊥ line were also observed upon increasing the microwave 
power. The expected inter-Cu(II) distance of 3.5 Å (0.35 nm) would, in turn, be expected to yield features in the 
EPR spectrum due to dipolar coupling. In addition, any bridging ligand might be expected to lead to either 
further splitting of the spectrum, or loss of the spectrum completely, due to exchange coupling. Further analysis 
of the spectra did indeed yield some evidence for spin coupling and is presented in Figure S1 of the Supporting 
Information. A difference spectrum obtained by subtraction of the 0.1 mW spectrum from the 2 mW spectrum 
(Figure S1A) exhibited intensity at 3150 G (315 mT) and 3520 G (352 mT) that would not be expected for 
mononuclear Cu(II). The difference spectrum could not be comprehensively reproduced by computer 
simulation, but a reasonable model was obtained that invoked a Cu−Cu distance of 5 Å (Figure S1B). Close 
examination of the high-field region of the spectrum recorded at 2 mW also revealed a broad feature centered 
at 5000 G (500 mT) that was suggestive of a weak exchange interaction of about 0.2 cm−1. This feature is similar 
to that observed from a μ-hydroxy-bridged di-Cu center with a Cu−Cu distance of about 3.5 Å (23). However, for 
such a system, an easily observed half-field line would be expected but is not seen in the spectra of Cu-L1. For a 
longer distance of 5 Å, simulations indicated that the much less intense half-field line would have been obscured 
by even the small signal due to traces of Fe-L1 in the sample. Careful observation and simulation of the signals 
do suggest, then, that there is a subpopulation (30%) of the Cu(II) that experiences Cu−Cu spin coupling. 
However, while the precise magnitude of the Cu−Cu distance cannot be stated with any certainty, given the lack 
of an complete solution by simulation, it certainly appears to be significantly greater than 3.5 Å. Alternatively, if 
a Cu−Cu center with an inter-Cu distance of 3.5 Å is indeed present, there must be considerable structural 
inhomogeneity in the sample, such that a wide distribution of Euler angles and/or distances renders the 
expected dipolar features too broad to be observed. Either way, it appears that L1 does not form a well-defined 
dinuclear Cu center that structurally corresponds to the di-Zn center in the native enzyme. Up to 65% of the 
Cu(II) in L1 containing 1.7 equiv of Cu can be accounted for by apparently magnetically isolated Cu(II), although 
this figure should be treated as an upper limit due to the extensive overlap of multiple signals, including those 
with a putative dipolar component. Regarding the remainder, analogy can be drawn with the aminopeptidase 
from Vibrio proteolyticus (Aeromonas proteolytica), in which two Zn(II) ions at 3.5 Å apart can be substituted by 
two Cu(II) ions that form a center with an inter-Cu distance of 5 Å (30). 
The Cu-containing analogue of L1 did not yield a 1H NMR spectrum, and this result is not surprising given the 
very slow electron relaxation time exhibited by magnetically isolated Cu(II) (24). EPR suggested that only maybe 
30% of Cu(II) may exhibit relaxation-enhancing magnetic interactions that would facilitate observation of an 
NMR signal, and these interactions are likely to be of a number of types or a distribution, rather than a discrete 
interaction typical of a well-defined dinuclear site. While the Ni-containing analogue of L1 did not yield an EPR 
spectrum, Ni(II) exhibits an electronic relaxation time of 10−13−10−11 s (24), which makes Ni(II) an excellent metal 
ion for 1H NMR studies. The 1H NMR spectrum of the Ni-containing analogue of L1 showed four resolved, 
paramagnetically shifted peaks: one peak at 18 ppm and three peaks between 55 and 80 ppm (Figure 4A). Peaks 
a, c, and d integrated to one proton each, and peak b integrated to two protons. Peak b was assigned to a 
nonexchangeable proton, possibly an ortho proton on a Ni(II)-bound histidine (24). Peaks c and d disappear 
completely when the buffer in the Ni-L1 samples is exchanged with buffer in 90% D2O, suggesting that these two 
protons can be assigned to NH protons on metal-bound histidines (Figure 4B). This result strongly suggests that 
Ni(II) binds to the Zn2 site in L1, since the Zn2 site has two metal binding histidines (25). We cannot 
unambiguously rule out the possibility that Ni(II) binds in a position that uses metal binding histidines from both 
the Zn1 and Zn2 sites. While this behavior has been reported for Mβl BcII (26), the use of ligands from both sites 
to bind a single equivalent of metal has not been reported in any of the structural studies on L1. 
 
Figure 4. 1H NMR spectra of Ni-L1. (A) Spectrum of Ni-L1 in buffer containing 10% D2O, (B) spectrum of Ni-L1 in 
buffer containing 90% D2O, and (C) spectrum of Ni-L1 with nitrocefin in buffer containing 90% D2O. The enzyme 
concentration was 1.0 mM, and the buffer in these samples was 50 mM Hepes, pH 7.0. The spectra were 
collected at a temperature of 300 K on a 500 MHz NMR spectrometer. 
 
In order to probe the function of Ni(II) in the Zn2 site of Ni-L1, 1 mg of nitrocefin powder (to avoid dilution of the 
protein) was added to the Ni-L1 sample in 90% D2O. The 1H NMR spectrum was immediately obtained 
(Figure 4C), and a new peak at 65 ppm was observed. The intensity of this peak increased and stabilized over 15 
min. We assign this peak to a proton on product (Figure 4C). 
Pre-Steady-State Kinetic Studies on Cu- and Ni-Containing Analogues of L1 
In an effort to probe whether the different metal ions in Cu-L1 and Ni-containing L1 affected the kinetic 
mechanism of the analogues, pre-steady-state kinetic studies were carried out on the reaction of 50 μM Cu-L1 
or Ni-containing L1 with 50 μM nitrocefin (Figures 5 and 6). Stopped-flow fluorescence studies, in which changes 
in intrinsic tryptophan fluorescence were monitored over time, showed a rapid decrease in fluorescence over 
the first 0.05 s of the reaction and a relatively slower regain of fluorescence over the subsequent 1 s (Figure 5A) 
when using as-isolated Cu-L1. A similar stopped-flow fluorescence progress curve was observed with ZnZn-L1, 
and the fluorescence changes were attributed to changes in the fluorescence properties of Trp38 (19, 27), which 
is close to the metal ion in the Zn2 site (25), upon substrate binding. The stopped-flow fluorescence curve 
strongly indicates that Cu(II) in Cu-L1 plays a similar role as Zn(II) in the native enzyme. Stopped-flow UV−vis 
studies on Cu-L1 showed a rapid decrease in substrate concentration (rate = 3.6 ± 0.1 s−1), and a rapid formation 
of product (rate = 2.6 ± 0.1 s−1), which matched the fluorescence recovery (2.8 ± 0.1 s−1). The rate of 
intermediate decay (rate = 1.0 ± 0.1 s−1) was slower than the rate of product formation. The rapid kinetic studies 
also revealed the presence of significant amounts of reaction intermediate, which absorbs at 665 nm. However, 
the intermediate in the reaction of Cu-L1 with nitrocefin was only 15% of that observed for ZnZn-L1 (21). 
 
Figure 5. Stopped-flow kinetic studies on Cu-L1. (A) Stopped-flow fluorescence trace of the reaction of 50 μM 
Cu-L1 and 50 μM nitrocefin at 10 °C. (B) Stopped-flow UV−vis traces of the reaction of 50 μM Cu-L1 with 50 μM 
nitrocefin at 10 °C. The absorbance at 485 nm is due to the product, the absorbance at 390 nm is due to the 
substrate, and the absorbance at 665 nm is due to the intermediate. 
 
 
Figure 6. Stopped-flow kinetic studies on Ni-containing L1. (A) Stopped-flow UV−vis traces of the reaction of 50 
μM Ni-L1 with 50 μM nitrocefin at 10 °C. The absorbance at 485 nm is due to the product, the absorbance at 390 
nm is due to the substrate, and the absorbance at 665 nm is due to the intermediate. (B) Stopped-flow UV−vis 
traces of the reaction of 50 μM ZnNi-L1 with 50 μM nitrocefin at 10 °C. The absorbance at 485 nm is due to the 
product, the absorbance at 390 nm is due to the substrate, and the absorbance at 665 nm is due to the 
intermediate. (C) Stopped-flow fluorescence trace of the reaction of 50 μM ZnNi-L1 with 50 μM nitrocefin at 10 
°C. 
 
The pre-steady-state kinetic behavior of Ni-L1, which contains 1 equiv of Ni(II) and 0.3 equiv of Zn(II), was 
unusual. The substrate depletion progress curve showed a very rapid decrease in absorbance over the first 20 
ms of the reaction, followed by a linear decrease in absorbance until substrate was depleted (Figure 6). The 
intermediate progress curve showed a rapid increase, a relatively long presence of intermediate over 600 ms, 
and a decrease in intermediate concentration. The product formation curve appears to be linear over the first 
600 ms of the reaction with no apparent rapid phase like that seen in the substrate decay or intermediate 
formation plots (Figure 6A). The stopped-flow UV−vis plots of ZnNi-L1 (Figure 6B), which contained 1 equiv of 
Zn(II) and 1 equiv of Ni(II), were very similar to those of ZnZn-L1 (21). There was a rapid decrease (269 ± 20 s−1) 
in substrate concentration and increase (188 ± 1 s−1) in intermediate concentration and a decrease (15.0 ± 0.1 
s−1) in intermediate concentration that was similar to that of product formation (15.8 ± 0.1 s−1). The stopped-
flow fluorescence curve of this analogue showed the typical decrease (140 ± 3 s−1) in intrinsic tryptophan 
fluorescence (27), followed by a slower regain (12.3 ± 0.2 s−1) of fluorescence (Figure 6C). 
Discussion 
Recently, Hu et al. showed that the metalation of Mβl L1 is dependent on the bioavailability of metal ions (13). 
This study showed that mature L1, which is produced from an overexpression plasmid containing the gene for L1 
lacking the targeting sequence, could be isolated containing iron, zinc, or cobalt when the enzyme was 
overexpressed in minimal medium containing Fe(II), Zn(II), or Co(II), respectively. In an effort to extend this 
study, we used the same method to demonstrate that L1 containing 1.7 equiv of Cu(II) or 1.0 equiv of Ni(II) can 
be isolated. Our data show that L1 can bind ∼2 equiv of Zn(II), Co(II), Cu(II), or Fe and that the first three 
dinuclear metal ion-containing analogues are catalytically active, while the last analogue is inactive (13). Since 
the EPR spectrum of Fe-containing L1 shows evidence for an antiferromagnetically coupled Fe(III)Fe(II) 
center (28), it is possible that Asp120 bridges the two Fe ions and is not available for orienting the bridging 
solvent molecule for nucleophilic attack or proton transfer (29). 
L1 can also bind 1 equiv of Ni(II) in the Zn2 site, and the Ni(II)-containing analogue utilizes the same reaction 
mechanism as the wild-type enzyme, at least when nitrocefin is used as the substrate. This flexibility of the 
metal binding sites is unusual; however, there are examples of other metalloenzymes with similar properties. 
For example, AAP (aminopeptidase from A. proteolytica), which is an unrelated, dinuclear Zn(II)-containing 
enzyme, is also active containing dinuclear copper, nickel, and cobalt centers (30-33). In addition, several 
heterobimetallic analogues (CoZn, etc.) of AAP are active (30, 31). These heterobimetallic forms are possible 
because of the sequential metal binding properties of the enzyme. In L1, Zn(II) preferentially binds to the 
Zn1 site, which is made up of three histidines and one bridging hydroxide, and Co(II) and Ni(II) preferentially bind 
to the Zn2 site (ref 21 and data herein). The EPR data in the present study indicate two copper binding sites, one 
of high affinity (fully occupied) and the other of lower affinity (∼45% occupied). The high-affinity site provides at 
least three nitrogen ligands in the equatorial plane and is thus assignable to the Zn1 site. The lower affinity site is 
consistent with type 2 Cu(II), with nitrogen ligation, and with a mildly electron-withdrawing moiety ligated to 
Cu(II). These characteristics are all consistent with the Zn2 site being the low-affinity Cu(II) binding site. 
Contrarily, inconsistent with this proposal is the observation that the two Cu(II) signals are S = 1/2. The lack of 
EPR signals characteristic of dinuclear copper is not definitive evidence for the lack of a dinuclear center. 
However, a substantial amount of an EPR-silent dinuclear copper center would require that much of the copper 
in L1 is EPR-silent, and this is not the case. In addition, even strongly antiferromagnetically coupled Cu(II)−Cu(II), 
e.g., 50 cm−1(33), would have substantially populated excited states at ambient temperatures, and NMR signals 
would be expected. The available data suggest, then, that the low-affinity Cu site is not the Zn2 site. Cu(II) has a 
propensity to bind to amide nitrogen, even in the presence of available histidine, in a manner that is not 
generally observed for Zn(II) (34). This may account for binding of the second Cu(II) in an alternative site or sites. 
Cu(II) is similarly distributed in AAP between magnetically isolated sites and a dinuclear site with an inter-Cu 
distance of 5 Å, in contrast to the inter-Zn distance of 3.5 Å in the native enzyme. As mentioned above, we 
believe that the spin coupling in 2Fe-L1 is due to the recruitment of Asp120 as a bridging ligand, and EXAFS 
studies on this analogue are currently in progress to confirm this hypothesis. Importantly, 2Fe-L1 is catalytically 
inactive. A recent crystal structure of L1 showed 3 equiv of copper bound to the enzyme (Figure 7) (35). Two of 
the coppers were bound in the active site, and the M—M internuclear bond distance was 3.5 Å, which is 
probably too long for a dinuclear metal center with a bridging hydroxide and a bridging carboxylate. A third 
copper, in complex with phenanthroline, was bound at a remote site, utilizing a single His (His51) to bind to the 
enzyme. In the present case, with only 1.7 equiv of Cu(II) bound and with both EPR and NMR evidence against a 
3.5 Å Cu−Cu center, it seems likely that only the Zn1 site of the dinuclear center is occupied, with additional 
copper bound at one or more other sites, one possibly within 5 Å of Zn1. 
 
Figure 7. Left: Structure of the Cu-containing analogue of L1 showing the third Cu binding site. Right: Metal 
binding site of the Cu-containing analogue of L1. 
 
1H NMR studies on ZnNi-L1 yielded novel information about product binding to the metal center. The 1H NMR 
spectra (Figure 4) of Ni-L1, which binds 1 equiv of Ni(II) and 0.3 equiv of Zn(II), showed that only two histidines 
were bound to the paramagnetic metal ion. We cannot unambiguously rule out the possibility that Ni(II) 
coordinates one histidine from the Zn1 site and one histidine from the Zn2 site; however, this type of binding 
mode is unprecedented in studies on L1. In addition, the NMR spectrum of the NiZn sample showed that the 
nonsolvent-exchangeable peak (peak b in Figure 4) did not shift, suggesting that Ni(II) did not change binding 
ligands upon addition of Zn(II) (data not shown). The fact that Ni-L1 contains some Zn(II), that Zn(II) can be 
added to Ni-L1 to generate a more active analogue, and that there are only two histidines bound to Ni(II) 
strongly suggests that Ni(II) is bound in the consensus Zn2 site in L1. Peak c in Figure 4A and peak c* in Figure 4C 
are shifted downfield to similar positions, suggesting similar chemical environments for both protons. Given that 
the proton corresponding to peak c (Figure 4A) is assigned to the remote, solvent-exchangeable proton on a 
Ni(II)-bound histidine (proton is two bonds or three atoms from Ni(II)), it is possible that the proton 
corresponding to peak c* in Figure 4C is similarly positioned away from the Ni(II) ion. If Ni(II) binds to the 
nitrocefin product via the ring-opened nitrogen (5), the only proton that is two bonds (three atoms) away from 
Ni(II) is the proton on the 7-position of the product. This proton is not solvent-exchangeable, like peak c*, and 
we tentatively assign peak c* to this proton. To our knowledge, this is the first NMR spectroscopic evidence of 
an enzyme−product species with the product coordinated to the metal center in the Mβl’s. The observation of 
the EP complex in NMR studies is surprising, given the prediction that the KD for the EP complex was predicted 
to be >350 μM (36). Nonetheless, this observation validates the assumption, made in several kinetic 
mechanisms (7, 36), that a distinct EP can form. 
Pre-steady-state kinetic studies showed that both Cu-L1 and ZnNi-L1 utilize a similar kinetic mechanism 
(tryptophan fluorescence behavior, reaction intermediate) to hydrolyze nitrocefin as ZnZn-L1 and CcrA 
(Figures 5 and 6) (19, 37); however, the kinetic behavior of the Cu-L1 analogue is different. The rate of product 
formation in Cu-L1 is similar to the rate of fluorescence regain (2.6 and 2.8 s−1, respectively); these rates are 
higher than the rate of intermediate decay (1 s−1) and suggest that Cu-L1 may utilize two different pathways to 
hydrolyze nitrocefin. One pathway, which accounts for <30% of the turnover, utilizes an intermediate, as shown 
by the species that absorbs at 665 nm in Figure 5B. It is tempting to speculate that the catalytic species 
responsible for this is the subpopulation of L1 in which a dinuclear center is formed, albeit one with a longer 
intermetal distance than in native enzyme. This, in turn, suggests a role for the second metal ion in stabilizing 
the “665 nm intermediate”. The remaining turnover, 70%, is accomplished through a mechanism in which no 
intermediate can be detected. Given that up to 65% of the Cu(II) in L1 is present as magnetically isolated Cu(II), it 
appears that most of the turnover is accomplished by a mononuclear Cu(II) ion that resides in the Zn1 site. The 
lack of an adjacent, additional metal ion may force the adoption of an alternative mechanism, in which the 665 
nm intermediate is not formed. This seems unlikely, given the comparable catalytic competencies of the two 
mechanisms. Alternatively, in the absence of a second metal ion, there is nothing to stabilize the 665 nm 
intermediate; the rate of its decay is much faster than the rate-limiting step of the reaction, and it is not 
detected in the pre-steady-state kinetic experiments. 
The hydrolytic activity of ZnNi-L1 was much higher compared than that of Cu-L1. The rates of substrate 
depletion and intermediate formation were very high, while the rates of production formation and intermediate 
decay were >10-fold lower (Figure 6). The unusual shape of the progress curve of intermediate is most likely due 
to the sample containing mixtures of ZnNi- and Ni-containing analogues (Figure 6A). When this sample is made 
to be predominantly ZnNi (Figure 6B), the shape of the progress curve for intermediate is identical to those of 
ZnZn-L1 (21). The presence of large amounts of reaction intermediate strongly suggests that the rate-limiting 
step of nitrocefin hydrolysis by Ni-L1 is protonation of the reaction of intermediate (36). 
Steady-state kinetic studies on metal-substituted analogues of L1 yielded surprising results. The most efficient 
enzyme, in terms of kcat/Km, is the ZnZn-analogue (Table 2). There are three analogues that presumably have 
Zn(II) in the Zn1 site: ZnCo-, ZnFe-, and ZnNi-L1; however, these analogues exhibit significantly different steady-
state kinetic properties with the substrates tested. ZnCo-L1 (21) exhibits steady-state kinetic constants similar to 
those of ZnZn-L1 for penicillin G, but the Km values for studies with cefaclor, imipenem, and nitrocefin are much 
larger. On the other hand, the ZnFe- and ZnNi-containing analogues of L1 do not hydrolyze penicillin G at all, 
exhibit decreased kcat values when using cefaclor as substrate, exhibit increased kcat values when using imipenem 
and nitrocefin as substrate, and exhibit increased values of Km for all substrates tested. The metal-substituted 
analogues with metal ions other than Zn(II) in the Zn1 site (CoCo- and CuCu-L1) exhibit kinetic properties that do 
not follow any trend. For example, CoCo-L1 hydrolyzes penicillin G with significant kcat and Km values, while 
CuCu-L1 does not hydrolyze the same substrate. CoCo- and CuCu-L1 exhibit very large values for kcat for some 
substrates; however, the Km values for all tested substrates are also significantly higher. It is not clear why the 
metal-substituted analogues exhibit different steady-state kinetic behavior, but the data suggest that substrate 
preference is somewhat modulated by the identity of the metal ion(s) in the active site of L1. However, we 
cannot rule out that some of the enzyme samples contain mixtures of metal centers, since the concentration of 
adventitious Zn(II) in the assay buffers is ca. 100 nM, while the enzyme concentration in the same assays is 10 
nM. Studies to probe the metal centers in each of the analogues are ongoing in an effort to probe whether M−M 
bond distances affect the kinetic behavior of the analogues. 
The results of this work demonstrate further that the metal binding sites, particularly the Zn2 site, in L1 are very 
flexible and can accommodate a number of different divalent metal ions. This flexibility can possibly offer a 
competitive advantage to organisms that produce L1 when the organisms are threatened with β-lactam-
containing antibiotics. The ability of L1 to be active containing a number of different metal ions would allow 
bacteria to survive in environments with limited Zn(II) concentrations. The different substrate preferences with 
different metal centers may be evolutionarily exploited in the future to resistant inhibitors that resemble 
substrate. 
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